Sustained Passive Physiologic Monitoring Using a Device-Agnostic AI-Enabled Platform: A Pilot Study in Chronic Heart Failure Patients

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Equity/Stock(s)/Options - Edwards Lifesciences; Alyf, Inc</li></ul>